BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease Life Science Investing
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development Life Science Investing
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204 Life Science Investing
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations Life Science Investing
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases Life Science Investing
Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform Life Science Investing
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries Life Science Investing
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary , Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network Life Science Investing
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology Annual Meeting Life Science Investing